year three, quarter three malaria diagnosis and …

24
YEAR THREE, QUARTER THREE MALARIA DIAGNOSIS AND TREATMENT PROGRESS REPORT: April –June 2018 Private Health Sector Project

Upload: others

Post on 19-Jan-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

YEAR THREE, QUARTER THREE MALARIA

DIAGNOSIS AND TREATMENT PROGRESS

REPORT: April –June 2018

Private Health Sector Project

The Private Health Sector Project is a technical assistance project to support the Government of Ethiopia.

The Private Health Sector Project is managed by Abt Associates Inc. and is funded by the United States Agency for

International Development (USAID), under Contract No. AID-663-LA-16-00001.

Recommended Citation Private Health Sector Project, Year Three, Quarter Three Report (April–June 2018)

Report on Diagnosis and Treatment of Malaria in Private Facilities. 20 July 2018. Rockville, MD. Private Health Sector

Project, Abt Associates.

Submitted to: Dr. Mesfin Tilaye

Agreement Officer’s Representative

Health Network Program Advisor

USAID| Ethiopia

Addis Ababa, Ethiopia

Submitted by: Dr. Mesfin Teferi, Chief of Party

USAID| Private Health Sector Project

Abt Associates Inc. 1 6130 Executive Blvd

1 Rockville, Maryland 20852 1 T. 301.347.5000 1 F. 301.913.9061

1 www.abtassociates.com

YEAR THREE, QUARTER THREE

MALARIA DIAGNOSIS AND TREATMENT

PROGRESS REPORT

DISCLAIMER

The author’s views expressed in this publication do not necessarily reflect the views of the United States

Agency for International Development (USAID) or the United States Government

i

CONTENTS

Acronyms ................................................................................. 3

1. Program description ................................................... 4

1.1 General Overview ........................................................................... 4

1.2 Strategies ........................................................................................... 4

1.3 Objectives ......................................................................................... 4

2. Performance report .................................................... 5

2.1 Working with the Private Health Facilities ............................... 5

2.2 Working with work place facilities ............................................. 5

2.3 Clinical seminars .............................................................................. 6

2.4 Case management training ............................................................ 6

2.5 Site visit and Support ...................................................................... 7

2.5.1 Gambella region visit by central team .......................... 7

2.6 Summary of JSS findings from other regions ............................ 9

2.7 Onsite orientation to regional PHSP and PHFA program

officers ............................................................................................. 10

2.8 Malaria laboratory support ......................................................... 10

2.9 DQAs ............................................................................................... 11

2.10 Research ................................................................................... 11

2.11 Service Delivery ...................................................................... 12

2.12 Other activities ....................................................................... 16

3. Challenges .................................................................. 16

4. Major activities for year three, quarter Four ......... 16

Annex A: Malaria Program Activity Matrix, Year Three,

QUARTER THREE April –June 2018................................... 17

Annex B: List of facilities reported in Quality1mprovement

for Malaria diagnosis and treatment ................................... 19

ii

List of Tables

Figure 1: Malaria case management training for FDRE sugar corporation

workers, 7-11 May 2018 .....................................................................7

Table 1: JSS Summary (April –June 2018) .......................................................9

Table 2: Malaria Diagnosis and Treatment at Private Health Facilities

(April –June 2018) .............................................................................. 12

table 3: Malaria cases treated, admitted, and referred and malaria-

related deaths in private health facilities (January-March 2018)

................................................................................................................. 13

Table 4: Malaria cases by age and sex in PHSP-supported facilities (April

–June 2018) .......................................................................................... 14

List of Figures

Figure 1: Malaria case management training for FDRE sugar corporation

workers, 7-11 May 2018 .....................................................................7

Figure 2: Trends In Malaria Diagnosis and Treatment at Project-Assisted

Private Facilities, Jul 017_to June 2018 ......................................... 15

3

ACRONYMS

AL Artemether lumefantrine

CQ Chloroquine

EPHI

EQA

DQA

FDRE

FMOH

HMIS

Ethiopian Public Health Institute

External Quality Assurance

Data Quality Assessment

Federal Democratic Republic of Ethiopia

Federal Ministry of Health

Health Management Information System

IEC Information, Education and Communication

IG Implementation Guidelines

JSS Joint Supportive Supervision

OPD

PHEM

PFSA

PHFA

Out-patient Department

Public Health Emergency Management

Pharmaceuticals Fund and Supply Agency

Private Health Facility Association

PHSP Private Health Sector Project

PMI President’s Malaria Initiative

PPM Public-private Mix

PQ Primaquine

PT Panel Testing

RDT Rapid Diagnostic Test

RHB

RRF

Regional Health Bureau

Requesting and reporting form

RRL Regional Reference Laboratory

SNNPR Southern Nations, Nationalities, and Peoples Region

TAC Technical Advisory Committee

TB

USAID

Tuberculosis

United State Agency for International Development

4

1. PROGRAM DESCRIPTION

1.1 General Overview

The Private Health Sector Project (PHSP) is a United States Agency for International Development

(USAID)-funded project, with partial funding from the President’s Malaria Initiative (PMI). The project

provides technical assistance to enable private and workplace health facilities in Ethiopia to provide

quality malaria diagnosis and treatment. In the reporting period (April-June 2018) , the project provided

technical support to 163 facilities (15 in Afar, 28 in Amhara, 15 in Benishangul Gumuz, 14 in Dire Dawa,

12 in Gambella, 32 in Oromia, 19 in Southern Nations, Nationalities, and Peoples Region [SNNPR], and

28 in Tigray). Within the same period, these facilities tested 86,309 patients suspected for malaria,

diagnosed 14,846 patients, and treated them accordingly. During the next quarter, PHSP will continue

supporting those facilities to provide standard and quality malaria diagnosis and treatment services.

1.2 Strategies

The project pursues the following strategies to achieve its goals:

Conducting policy dialogue with Regional Health Bureaus (RHBs) to engage private facilities in

public-private mix (PPM)-based malaria case management, policy dialogue, and advocacy.

Conducting rapid assessments to map the geographic distribution of the migrant and mobile

work force.

Developing a PPM implementation guideline for malaria prevention and control through the

private health sector.

Building the capacity of health providers (case managers, laboratory and pharmacy/supply chain

professionals, ) through team training, joint supportive supervision (JSS), and mentoring.

Supporting implementation of PPM to expand the number of service sites offering malaria care.

Providing technical assistance to the Federal Ministry of Health’s (FMOH) malaria program.

Working through partnerships with other stakeholders to improve access to effective and

efficient malaria care services.

1.3 Objectives

The malaria component of the project has the following objectives:

Increase access to and uptake of malaria services in private health facilities.

Enhance capacity of local partners to ensure the sustainability of PPM partnerships.

Enhance pharmaceutical supply chain management and rational drug use at private health

facilities, including work places.

Enhance program learning and innovative ventures in malaria care and treatment.

5

Generate evidence on malaria service needs of the migrant and mobile workforce for decision

making and programming.

2. PERFORMANCE REPORT

2.1 Working with the Private Health Facilities

During the reporting period (April – June 2018), PHSP continued supporting the 163 private and work

place health facilities in all regions of the country, except Somalia, Harari, and Addis Ababa city

administrative state.

2.2 Working with work place facilities

PHSP continued supporting 12 Federal Democratic Republic of Ethiopia (FDRE) Sugar corporation

health facilities and other nine work place health facilities located in Amhara, Afar, Oromiya, SNNPR and

Tigray regions. These facilities are serving large number of permanent and seasonal migrant workers

who are at high risk of malaria as most of the places are stratified in the high risk category.

The 12 FDRE Sugar Corporation have around 21,842 permanent employees and 42,378 seasonal and

migrant workers and the health facilities with different structures in the factories are providing the

malaria diagnosis and treatment services for a total population 256,880 peoples.

The other 9 work place facilities have a total number 7,383 permanent and 78,758 seasonal workers and

the health facilities are serving for more than 100,000 total population.

Working with FMOH, RHBs, and Stakeholders

PHSP carried out the following activities with the FMOH, RHBs, and other stakeholders during the

reporting period:

Attended the Technical Advisory Committee (TAC) meeting where updates of the program

were shared and successfully advocated with the TAC about the benefits of having a PPM-

malaria IG policy document

Federal Ministry of Health established a task force to develop PPM-malaria Implementation

Guidelines document. The task force is composed of representatives from the following

partners: FMOH, USAID/PMI, ICAP, Transform PHCP, WHO, UNICEF and PHSP.

Developed the PPM-malaria Implementation Guidelines draft document and shared with the task

force to enrich their work further.

Attended the annual USAID/MOP meeting and presented the project performance and future

plans.

Facilitated the USAID/PMI PPM-malaria facility visit in Gambella by preparing brief documents,

demonstrating the performance of the project in the supported facilities, and gathered

important feedback to improve future project implementation.

Attended a workshop of “Annual review meeting on TB, HIV and Malaria external quality

6

assurance (EQA)” organized by EPHI. During the workshop, PHSP emphasized the significance

of integrating the malaria EQA with the well-established TB EQA in all private health facilities.

During the workshop participants reached the following consensuses:

1. Improve the EQA system of malaria.

2. Implement the malaria EQA in all government and private health facilities.

3. Strengthen the capacity and competency of regional laboratories and EQA centers

through Panel Testing (PT) and international trainings.

4. Revise and prepare standard training materials on malaria laboratory.

5. Revise the curricular structure on malaria and tuberculosis (TB) microscopy.

2.3 Clinical seminars

The project conducted five sessions of a one day clinical seminar in Hawassa, Humera, Awash, Assosa

and Gambella to 121 physicians and health officers working in the out-patient departments (OPDs). The

aim of the seminar was to update targeted clinicians with the new malaria diagnosis and management

process and to share with the providers the important parameters that can be used to monitor the

malaria program in their facilities.

2.4 Case management training

In collaboration with the FMOH and FDRE Sugar Corporation, the project organized a training to build

the capacity of clinicians and laboratory workers and provided one round of the recent malaria case

management training in Adama.

Objectives of the training:

Build the capacity of the clinicians to provide quality and standard clinical care for patients with

malaria, and update the other staff with a one day orientation session within the facility.

Build the capacity of laboratory professionals from the same facilities to improve their skills in

malaria microscopy and synchronize with the standards.

The outcome of the training:

A total of 30 clinicians (27 males and three females) and 12 laboratory professionals from the 12

FDRE Sugar Corporation health facilities attended and completed the training.

The full packages of the training materials and a one day update orientation document were

given in hard and soft copies.

All trainees received post- test and 27 (90%) of them scored the minimum requirement for

certification.

After receiving the training, the trainees provided a one day update orientation session to 256

professionals within their facility.

7

Figure 1: Malaria case management training for FDRE sugar corporation workers, 7-11

May 2018

2.5 Site visit and Support

During this quarter, the project conducted JSS and mentoring to all PPM malaria sites.

2.5.1 Gambella region visit by central team

In Gambella region, the central PHSP team visited 10 PPM health facilities using the JSS checklist

and found the following strengths and gaps:

Major Strengths:

All of the facilities are providing the malaria diagnosis and treatment services.

50% of the facilities have trained manpower on the recent malaria case management guidelines

and 90% of the facilities have trained laboratory professionals on malaria microscopy.

All facilities are reporting cases to the Woreda health office using the health management

information system (HMIS) reporting form.

All facilities have one of the job aids at the OPD and in the laboratory.

All facilities are using the malaria morbidity and comprehensive laboratory registers properly.

80% of the facilities are using microscopy as the only diagnostic tool to diagnose malaria.

90% of the facilities are providing the first dose Artemether lumefantrine AL at the OPD.

60% of the facilities are providing the single dose Primaquine (PQ) for P. falciparum patients.

80% of the facilities have the adult AL at their drug cabinet.

All facilities perform two of the emergency tests (Random Blood Sugar, Hemoglobin) needed to

support the diagnosis of severe malaria.

90% of the facilities have PQ tablets at their drugs cabinet.

All facilities have Giemsa solution at their store.

0

20

40

60

80

100

120

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 24 25 26 28 30 31 32 34 35

SCO

RE

%

PARTICIPANTS' CODE #

Pre-test (%) Post-Test (%)

8

All facilities have slides box and started to store slides for rechecking.

100% of the facilities were involved during the first malaria laboratory EQA in the region.

Major gaps:

None of the facilities are reporting using the public health emergency management (PHEM)

reporting system.

Two facilities (20%) are using both rapid diagnosis test (RDT) and microscopy to diagnose

malaria.

Two facilities are using PQ for the radical cure purposes.

Five facilities (50%) are giving treatment clinically for slide negative uncomplicated cases.

Not all facilities are determining parasite load.

70% of the facilities do not have the paediatric AL formulations.

Data discrepancy between the two registers and the monthly HMIS reports.

Only 40% of the facilities had the Artesunate injection during the supervision time.

Only 30% of the facilities had methanol, and none of them are performing thin smear.

Some facilities are not storing the anti-malaria drugs in a lockable cabinet, and only one facility is

storing the prescription of the anti-malaria drugs for auditing.

Facilities were using Artesunate injection for non- complicated cases.

Actions taken:

Clinical seminar, onsite orientation and support given to the clinicians, focal persons and the

laboratory professionals based on the identified technical and other gaps.

Discussed with the regional staffs and agreed on the following action points:

o Distribute methanol solution once the regional laboratory receives it.

o Provide the important anti-malaria drugs without any bureaucratic issues to the PPM

facilities based on the requesting and reporting form (RRF).

o Provide the EQA feedback to each facility.

o Continue doing the EQA every quarter.

o Accommodate the PPM facilities during the regional JSS.

o Disaggregate the data of the private facilities’ contribution during the HMIS report to the

FMOH.

o Facilitate the referral linkage between the PPM facilities and Gambella Hospital.

o Recruit a potential temporary mentor who will assist the project in close follow up of the

program activities.

o Identify new private facilities in the city and nearby cities who will be assessed for

enrolment by the project.

9

2.6 Summary of JSS findings from other regions

Table 1: JSS Summary (April –June 2018)

Gap Reason Action taken Responsible

body

Timeline

1 Adequacy of

trained staff for

malaria diagnosis

Due to high turnover,

some facilities have no

trained staff, especially

in Amhara region.

Arrange a clinical

seminar and provide the

case management

training

PHSP Q-IV

2 Adequacy of

malaria lab

equipment for

diagnosis in the

health facility

Lack of methanol and lens cleaning solution in most facilities.

Poor quality giemsa

solution in some

facilities

Discussed with Ethiopian

Public Health Institute

(EPHI) and Regional

Reference Laboratory

(RRL) to provide the

facilities with standard

reagents including the

methanol.

RRL and

EPHI

Q-IV

3 Adequacy of

malaria treatment

drugs at the health

facility (none

complicated,

severe, & pre

referral)

Shortage of

Artesunate and

quinine injections.

Stock out of AL

Shortage of PQ

Discussed with the regional PFSA hubs to provide them the drugs based on the RRF. Encouraged the PPM facilities to use the injections only as a pre-referral treatment for severe cases.

Advised the facilities to

request drug before

stock out using proper

RRF.

PPM

facilities

and PFSA

Q-IV

10

2.7 Onsite orientation to regional PHSP and PHFA program officers

The Central PHSP team provided onsite orientation on the major clinical updates, newly developed

supportive supervision and mentoring checklists, and onsite demonstrations on how to utilize the

checklists to PHSP regional program officers and PHFAs in SNNPR region.

The aim of the orientation was:

To update their knowledge with the recently revised malaria case management guidelines.

To start utilizing the checklists for the upcoming supervisions and mentoring.

Refresh on the basics of supervision and mentoring activities.

2.8 Malaria laboratory support

Training on Malaria Microscopy:

Provided malaria microscopy training for 30 laboratory professionals (M=26, F=4) selected from

Afar, Amhara, Oromia, Tigray, & SNNPR private and work place health facilities.

Provision of Job aids

Malaria Microscopy Job aids, WHO bench aids and SOPs were provided to Gambella and

Benishangul Gumuz PPM malaria sites.

Supportive supervision findings of the malaria laboratory diagnosis

Supportive supervision was conducted in 71 private health facilities in Amhara Oromia and SNNP

regions.

The comprehensive laboratory register is available in 80% of the health facilities.

WHO bench aid, SOPs and other provider support tools are available in 50% of the private

facilities.

All facilities are not doing thin film..

Very low malaria microscopy EQA coverage/participation..

Shortage of microscope cleaning solution and methanol/ethanol in most facilities.

Many health facilities are not performing IQC with known positive and negative slides.

11

Malaria EQA

PHSP supported Gambella and Benishangul Gumuz regional laboratories to run the first malaria

microscopy EQA in the regions. A total of 27 PPM-malaria facilities (15 in Benishangul Gumuz &

12 in Gambella regions) have received onsite evaluation and random slide rechecking.(Detailed

findings presented in The following figure)

Figure: malaria microscopy service onsite evaluation EQA result at Private health clinics

in Gambella town May, 2010 E.C.

Afar RHB has already integrated the EQA system into the private sector and 15 PPM malaria

facilities received random slide rechecking and corresponding feedback.

The project attended the annual EQA meeting and reflected on the gap of EQA in the private

sector and a final strong direction by FMOH and EPHI to accommodate all the PPM malaria sites

during the regional laboratory quarterly EQA program.

2.9 DQAs

PHSP reviewed the data quality of Year Three Quarter One and Two by crosschecking the reported

findings with the recount findings in 11 facilities from Amhara, Oromiya and SNNPR regions. During the

process there was no disparity between the reported and recounted number of identified and treated

number of malaria cases in the facilities.

2.10 Research

In close collaboration with PMI, PHSP completed the first draft report of the research on “Monitoring of

human and mosquito behavior and attitudes towards malaria prevention and treatment in agricultural

development areas in Ethiopia”, and shared with all responsible personnel to comment on the report

before submitting for publications. Per PMI’s feedback, PHSP is expanding the research to include

implementation strategies and preparing a manuscript for publication. The project will also disseminate

the study findings to all stakeholders.

0102030405060708090

100

100

91.7

95

0 50.0

0

75.0

0

8.3

100

100

10075.0

91.7

0

91.7

85.7

78.5

83.5

91.7

0

8.3

5

100

50.0

100

25.0

100

91.7

0 0 025.0

8.3

100

8.3 14.3

21.5

17.5

8.3

Per

form

an

ce i

n %

Items/Practices

Ye…

12

2.11 Service Delivery

As mentioned above, PHSP provided technical support to facilities through training, site-level support, and linkage to anti-malarial commodity

supplies. During the quarter, 163 project-supported facilities reported and the performance is summarized in the following tables and figures.

Table 2: Malaria Diagnosis and Treatment at Private Health Facilities (April –June 2018)

Region

All

malaria

suspected

cases

Total

cases

Microscopy RDT Percent

confirmation

Dx TBF Pos % PF PV Mixed TRDT Pos % PF PV Mixed

Afar 6672 789 6515 739 11.3 457 251 13 157 50 31.8 33 17 0 100%

Amhara 17732 1140 17225 1057 6.1 576 422 59 507 83 16.4 42 36 5 100%

Beneshangul

Gumuz 11518 3558 11518 3558 30.9 1687 1866 5 0 0 0 0 0 0

100%

Dire Dawa 933 52 933 52 5.6 34 18 0 0 0 0 0 0 0 100%

Gambella 8054 4766 8054 4766 59.2 4124 498 144 0 0 0 0 0 0 100%

Oromia 17686 440 16983 409 2.4 168 230 11 703 31 4.4 20 11 0 100%

SNNPR 17501 2982 17265 2903 16.8 1683 1031 189 236 79 33.5 53 26 0 100%

Tigray 6213 1119 5585 853 15.3 426 419 8 628 266 42.4 224 33 9 100%

Total 86309 14846 84078 14337 17.1 9173 4735 429 2231 509 22.8 372 123 14 100%

NB: TBF=total blood film, pos=positive , Dx=diagnosis, PF=plasmodium falciparum, PV=plasmodium vivax, TRDT=total rapid diagnostic tests

13

Table 3: Malaria cases treated, admitted, and referred and malaria-related deaths in private health facilities (January-March

2018)

NB: CQ=chloroquine, AL=artemether lumefantrine, AM=artemether

Region Total Cases Total

treated

Treated Number of Malaria cases

AL CQ Quinine AM Artesunate Admitted Referred Deaths

Afar 789 789 482 268 0 32 7 0 0 0

Amhara 1140 1140 610 456 0 73 1 0 0 0

Beneshangul Gumuz 3558 3558 1687 1852 0 19 0 0 0 0

Dire Dawa 52 52 31 18 0 0 3 0 1 0

Gambella 4766 4766 4268 498 0 0 0 0 0 0

Oromia 440 440 183 235 5 8 9 0 1 0

SNNPR 2982 2982 1761 1061 52 24 84 0 9 0

Tigray 1119 1119 577 452 0 84 6 0 0 0

Total 14846 14846 9599 4840 57 240 110 0 11 0

14

Table 4: Malaria cases by age and sex in PHSP-supported facilities (April –June 2018)

Region Total Cases

treated

Age in Years and Sex Disaggregation

< 5 5 - 14 >=15 PW*

Total

Male Female Male Female Male Female Male Female

Afar 789 39 29 66 27 421 207 0 526 263

Amhara 1140 76 63 96 67 520 318 1 692 448

Beneshangul Gumuz 3558 574 441 287 298 969 989 20 1830 1728

Dire Dawa 52 1 1 2 1 31 16 0 34 18

Gambella 4766 452 338 303 259 1686 1728 3 2441 2325

Oromia 440 25 10 35 27 218 125 0 278 162

SNNPR 2982 103 160 463 502 1063 691 1 1629 1353

Tigrai 1119 51 30 99 69 614 256 0 764 355

All Regions 14846 1321 1072 1351 1250 5522 4330 25 8194 6652

15

Figure 2: Trends In Malaria Diagnosis and Treatment at Project-Assisted Private Facilities, Jul 017_to June 2018

10771

21914 2255021202

11103

14846

10113

20,738

2255021185

11103

14846

75.0%

80.0%

85.0%

90.0%

95.0%

100.0%

105.0%

0

5000

10000

15000

20000

25000

Jan_Mar17 Apr_Jun17 Jul_Spet17 Oct_dec17 Jan_March18 Apr_Jun18

% C

on

firm

ed

# o

f M

alar

ia C

ase

Diagnosed Malaria Treated Malaria % Confirmed Malaria

16

2.12 Other activities

Prepared a poster presentation slides for the East African private health sector forum.

3. CHALLENGES

A few PPM facilities in Gambella Region lack commitment and motivation.

Difficulty in accessing methanol and lens cleaning solutions by most of the PPM facilities.

Difficulty in getting all febrile cases from the registers.

Interrupted supplies of the anti-malaria drugs from PFSA.

Irrational use of the injectable Arthesunate.

Poor EQA coverage to the PPM facilities.

None

4. MAJOR ACTIVITIES FOR YEAR THREE, QUARTER

FOUR

Continue supporting the FMOH in the development of PPM Malaria Implementation Guidelines,

provision of training of trainer trainings.

Continue supporting the 163 health facilities to provide quality malaria services.

Provide two rounds of malaria case management trainings.

Provide clinical mentoring to the high yielding facilities.

Provide targeted and integrated supportive supervision to sample facilities in all regions.

Conduct a clinical seminar in Amhara region.

Strengthen the malaria EQA system by supporting the regional laboratories in high malaria

yielding facilities.

Disseminate the findings of the study on “Monitoring of human and mosquito behavior and

attitudes towards malaria prevention and treatment in agricultural development areas in

Ethiopia” and prepare the study report for dissemination.

Develop a pocket reference book for clinicians.

Assure the data quality by performing DQAs.

Organize a clinical seminar for clinicians working in Addis Ababa.

Discuss in the TAC meeting the development a standard supportive supervision and mentoring

checklist that also addresses the private sector.

Finalize the development and dissemination of the PPM malaria implementation guideline

17

ANNEX A: MALARIA PROGRAM ACTIVITY MATRIX, YEAR THREE,

QUARTER THREE APRIL –JUNE 2018

Indicator Indicator /output Planned

Achieved

1 Support the FMOH in the development of PPM

Malaria implementation guidelines

PPM-malaria

Implementation guideline 1 1

2 Conduct dissemination workshop on PPM- Malaria

Program IG

# of workshops organized 0

3 Participate in the National High Impact countries

Global Fund proposal development

# of workshops

organized attended

cancelled

4 Participate in and sponsor the national celebration

of World Malaria Day 2018

# of events/ proceedings 1 1

5 Provide parasitological diagnostic services to 98%

(393,310) of patients suspected (401,337) for

malaria in 214 supported health facilities

Proportion of

parasitological identified

malaria cases

>98% 100 %

6 Provide malaria treatment for 100% (62,929) of

malaria patients in the 168 facilities

% of patients who

received the malaria

treatment

100% 100 %

7 Provide two rounds of malaria case management

training for doctors, health officers and nurses.

# of training participants 60 30

8 Provide four rounds of four-day training on malaria

diagnosis to 140 Lab professionals # of training participants 60 30

9 Print and distribute different sets of job aids and

treatment guidelines to 214 private health facilities

(Lab Bench aids/guidelines/ clinical standard

operating procedures distributed)

# of facilities who

received and are using the

job aids

214 163

10 Conduct JSS # of facilities that received

JSS 2 1

11 Conduct clinical mentoring for the new regions # of facilities that received

mentoring 2 1

18

Indicator Indicator /output Planned

Achieved

12 Conduct clinical seminars for the supported

private health facilities

# of participants who

attended the clinical

seminars

60 121

13 Ensure the malaria EQA test for 168 private

facilities is done

# of facilities that received

EQA tests 168 42

14 Conduct the study in collaboration with PMI on

‘Monitoring outdoor biting of mosquitoes and

human behavior and attitudes towards malaria

prevention and treatment in agricultural

development areas in Ethiopia”

# assessment report

1

1

15 Publish findings of the formative assessment on

migrant workers situation once it goes through the

quality assurance process and gets permission

from the responsible bodies for publishing.

# of published articles

1 0

16 Conduct a rapid assessment on the prevalence,

diagnosis and management of patients with malaria

in selected private and public health facilities in

Addis Ababa city.

# assessment report

1 0

19

ANNEX B: LIST OF FACILITIES REPORTED IN QUALITY1MPROVEMENT FOR

MALARIA DIAGNOSIS AND TREATMENT

During the reporting period 100% supported facilities reported malaria data to town/woreda office based on the national requirements through

HMIS.

Region Malaria sites

supported

Malaria site reported (April

–June 2018)

Addis Ababa 0 0

Afar 15 15

Amhara 29 29

Beneshangul Gumuz 15 15

Dire Dawa 14 14

Gambella 12 12

Harari 0 0

Oromia 32 32

SNNPR 18 18

Tigray 28 28

Total 163 163